53
Participants
Start Date
June 19, 2023
Primary Completion Date
September 13, 2024
Study Completion Date
September 13, 2024
SPH3127 Tablets with Dose A
See Arm description
SPH3127 Tablets with Dose B
See Arm description
SPH3127 Tablets placebo
See Arm description
Beijing Chao-Yang Hospital,Capital Medical University, Beijing
Shengjing Hospital affiliated to China Medical University, Shenyang
Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Tianjin Medical University General Hospital;, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Union Hospital Tongji Medical College Huazhong Universitu of Science and Technology, Wuhan
Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Renmin Hospital of Wuhan University, Wuhan
The First Affiliated Hospital,Sun Yat-sen University, Guangzhou
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
The First Affiliated Hospital of University of South China, Hengyang
General Hospital of Ningxia Medical University, Yinchuan
Huizhou First Hospital, Huizhou
Nanfang Hospital, Southern Medical University, Guangzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Affiliated Hospital of Hebei University, Baoding
The Second Hospital of Hebei Medical University, Shijiazhuang
The First Affiliated Hospital of Henan University, Kaifeng
The First Hospital of Hunan University of Chinese Medicine, Changsha
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan
Xi'an Central Hospital, Xi’an
Suining Central Hospital, Suining
Peking University Third Hospital, Beijing
Chifeng Municipal Hospital, Chifeng
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY